HTGC

Hercules Capital, Inc.
NYSEFINANCIAL SERVICESASSET MANAGEMENT

Key Statistics

Market Cap
$3.06B
P/E Ratio
8.14
EPS
$2.01
Beta
0.76
52W High
$17.93
52W Low
$12.98
50-Day MA
$17.09
200-Day MA
$16.27
Dividend Yield
9.60%
Profit Margin
67.70%
Forward P/E
8.61
PEG Ratio
0.53

About Hercules Capital, Inc.

Hercules Capital, Inc. (HTGC) is a leading publicly traded business development company that specializes in providing tailored debt and equity financing solutions to growth-oriented companies, primarily in the technology and life sciences sectors. Leveraging its deep industry knowledge and expertise, Hercules focuses on investing in high-growth firms, facilitating their scalability while ensuring a diversified portfolio that prioritizes credit quality and risk-adjusted returns. As a strategic partner for innovative ventures, Hercules Capital is dedicated to fostering sustainable value, making it an attractive investment opportunity for institutional investors seeking exposure to dynamic and emerging markets.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$566.17M
Gross Profit (TTM)$566.17M
EBITDA$474.26M
Operating Margin83.20%
Return on Equity17.30%
Return on Assets6.60%
Revenue/Share (TTM)$3.10
Book Value$12.32
Price-to-Book1.40
Price-to-Sales (TTM)5.41
EV/Revenue11.34
EV/EBITDA—
Quarterly Earnings Growth (YoY)54.70%
Quarterly Revenue Growth (YoY)8.50%
Shares Outstanding$187.16M
Float$171.51M
% Insiders1.95%
% Institutions36.55%

Historical Volatility

HV 10-Day
17.44%
HV 20-Day
15.39%
HV 30-Day
15.68%
HV 60-Day
18.42%
HV Rank
18.7%

Volatility is currently expanding

Analyst Ratings

Consensus ($19.50 target)
2
Strong Buy
6
Buy
1
Hold

Latest News

Hercules Capital Receives Affirmed BBB- Investment Grade Corporate and Unsecured Credit Rating from Fitch Ratings, Inc.

SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Fitch Ratings, Inc. (“Fitch”) has affirmed Hercules' investment grade corporate and unsecured credit rating of BBB-, and affirmed the Company's sec.

Business Wire10/16/2026Neutral
Hercules Capital Announces Date for Release of Third Quarter 2026 Financial Results and Conference Call

SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules,” “Hercules Capital,” or the “Company”), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2026 financial results conference call for Thursday, October 29, 2026, at 2:00 p.m. PT (5:00 p.m. ET). Hercules.

Business Wire10/15/2026Neutral
Rocket Pharmaceuticals Secures Strategic Credit Facility for Up to $150 Million from Hercules Capital

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, commercial-stage biotechnology company advancing genetic medicines for rare and life-threatening diseases, focused on inherited cardiovascular disorders, today announced that it has entered into a credit facility agreement with Hercules Capital, Inc. (NYSE: HTGC) for up to $150 million. The facility strengthens Rocket's financial position and provides access to additional capital to support executi.

Business Wire10/6/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HTGC and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More FINANCIAL SERVICES Stocks

Data last updated: 10/17/2026